A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis
Heiko Witt, Thomas Berg(Leipzig University of Applied Sciences), Giovanni Destro‐Bisol(Sapienza University of Rome), Hartmut Schmidt(Université Paris-Sud), W. J. Bock(University Hospital Ulm), Roberta Galavotti(University of Verona), Monika Koudová(Charles University), R Ammann(Institute of Oriental Manuscripts), Stefan Dahm(Max Delbrück Center), Klaus Rohde(Goethe University Frankfurt), Edit Szepessy(Boston University), Giulia Martina Cavestro(University of Parma), Milan Maçek(Charles University), Thilo Kähne(Otto-von-Guericke-Universität Magdeburg), Zoltán Kukor(Boston University), Núria Malats(Spanish National Cancer Research Centre), Julius Špičák(Institute of Clinical and Experimental Medicine), Olga Rickards(University of Rome Tor Vergata), Narcis Zarnescu(University of Pittsburgh), Johann Ockenga(Klinikum Bremen-Mitte), Hans Eiberg(University of Copenhagen), Francisco X. Real(Universitat Pompeu Fabra), Niels Teich(Leipzig University), Miloš Černý(Charles University), Nejat Akar(Ankara University), Jan B.�M.�J. Jansen(Radboud University Nijmegen), Miklós Sahin‐Tóth(University of California, Los Angeles), Matthias Löhr(Karolinska University Hospital), Eva Rausova(Charles University), Kaspar Truninger(University College Dublin), Joost P.H. Drenth(Amsterdam Neuroscience), Mario Bargetzi(Kantonsspital Aarau), Cédric Le Maréchal(Inserm), Thomas M. Gress(Universitätsklinikum Gießen und Marburg), Volker Keim(Leipzig University), Olfert Landt(TIB Molbiol (Germany)), Gabriella Spedini(Sapienza University of Rome), Carlo Castellani(Cystic Fibrosis Research Foundation), Eesh Bhatia, Markus M. Lerch(Ludwig-Maximilians-Universität München), Péter Simon(Universität Greifswald), Pier Franco Pignatti(University of Verona), Roland H. Pfützer(University of Pittsburgh), Hans-Ulrich Schulz(Otto-von-Guericke-Universität Magdeburg), Helmut Frieß(TUM Klinikum), Hans‐Jürgen Menzel(Universität Innsbruck), Walter Halangk(University Hospital Magdeburg), Pedro Moral(Hospital Universitari i Politècnic La Fe), Jian‐Min Chen(Zhongshan Hospital of Xiamen University), Frank Ulrich Weiß(Universitätsmedizin Greifswald)
Cited by 250
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
|JAMA|2010|1.4k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k